Skip to content
Home/Companies/Healthcare/Spore.Bio
Spore.Bio

Spore.Bio

Healthcare·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Spore.Bio?

Spore.Bio is currently owned by Singular Capital Partners through Singular Ventures II (2023 vintage), since 2025.

Hand-verified · updated 2026-05-17

Singular Capital Partners
Investor
Singular Capital Partners
Singular Ventures II · 2023 · VC

Key facts

HQFrance
SectorHealthcare
StatusActive
Websitewww.spore.bio

More from Singular Ventures II

Other portfolio companies in the same fund.

Apoha
Active
HealthcareUK· 2026
Lucis
Lucis
Active
HealthTechFrance· 2026
Lupa
Lupa
Active
HealthTechUK· 2025
Manual
Manual
Active
HealthcareUK· 2025
Orus
Orus
Active
FinancialsFrance· 2025
Peec AI
Active
SoftwareGermany· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Spore.Bio

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Spore.Bio?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Spore.Bio.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue